BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 16183287)

  • 1. The best use of adjuvant chemotherapy: new drugs and new use of "old" drugs.
    Hudis C
    Breast; 2005 Dec; 14(6):570-5. PubMed ID: 16183287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal sequence of anthracyclines and taxanes as adjuvant breast cancer treatment.
    Vici P; Viola G; Rossi S; Botti C; Vitucci C; Sergi D; Ferranti FR; Saracca E; Di Lauro L; Corsetti S; Foggi P; Fattoruso SI; Lopez M
    Clin Ter; 2008; 159(6):453-6. PubMed ID: 19169608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The use of adjuvant chemotherapy in stage II breast cancer in the last 25 years--a brief review].
    Sulkes A
    Harefuah; 2002 Apr; 141(4):374-8, 408. PubMed ID: 12017895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HER2 status and efficacy of adjuvant anthracyclines in early breast cancer: a pooled analysis of randomized trials.
    Gennari A; Sormani MP; Pronzato P; Puntoni M; Colozza M; Pfeffer U; Bruzzi P
    J Natl Cancer Inst; 2008 Jan; 100(1):14-20. PubMed ID: 18159072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-dense chemotherapy for primary breast cancer.
    Kümmel S; Rezai M; Kimmig R; Schmid P
    Curr Opin Obstet Gynecol; 2007 Feb; 19(1):75-81. PubMed ID: 17218856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is there a standard type and duration of adjuvant chemotherapy for early stage breast cancer?
    Hayes DF
    Breast; 2009 Oct; 18 Suppl 3():S131-4. PubMed ID: 19914531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New combination chemotherapy regimens in the primary treatment of operable breast cancer].
    Conti F; Sergi D; Foggi P; Abbate MI; Lopez M
    Clin Ter; 2007; 158(1):55-75. PubMed ID: 17405660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New approaches to adjuvant chemotherapy for breast cancer.
    Hudis C
    Pharmacotherapy; 1996; 16(3 Pt 2):88S-93S. PubMed ID: 8726587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of taxanes in breast cancer chemotherapy: what's new 15 years after?].
    Herceg D; Vrbanec D
    Lijec Vjesn; 2009; 131(5-6):133-41. PubMed ID: 19642533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-dense adjuvant chemotherapy for primary breast cancer.
    Fornier M; Norton L
    Breast Cancer Res; 2005; 7(2):64-9. PubMed ID: 15743513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant chemotherapy for breast cancer--"one fits all"?
    Bergh J
    Breast; 2005 Dec; 14(6):564-9. PubMed ID: 16243525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence-based use of taxanes in the adjuvant setting of breast cancer. A review of randomized phase III trials.
    Estévez LG; Muñoz M; Alvarez I; Fernández Y; García-Mata J; Ruiz-Borrego M; Tusquets I; Seguí MA; Rodríguez-Lescure A; Adrover E; Lluch A
    Cancer Treat Rev; 2007 Aug; 33(5):474-83. PubMed ID: 17561350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Early-stage breast cancer - strategies for adjuvant systemic therapy].
    Görner M; Just M; Gerull S
    Handchir Mikrochir Plast Chir; 2008 Aug; 40(4):230-8. PubMed ID: 18716990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of chemotherapy in breast cancer.
    Hussain SA; Palmer DH; Stevens A; Spooner D; Poole CJ; Rea DW
    Expert Rev Anticancer Ther; 2005 Dec; 5(6):1095-110. PubMed ID: 16336100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polychemotherapy for early breast cancer: results from the international adjuvant breast cancer chemotherapy randomized trial.
    Adjuvant Breast Cancer Trials Collaborative Group
    J Natl Cancer Inst; 2007 Apr; 99(7):506-15. PubMed ID: 17405995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Breast cancer].
    Ikeda T; Jinno H; Matsui A; Mitsui Y; Asaga S; Muto T; Wada M; Kitajima M
    Gan To Kagaku Ryoho; 2002 Sep; 29(9):1509-15. PubMed ID: 12355936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose adjuvant chemotherapy for breast cancer: state of the art.
    Cottu PH; Cuvier C; Espié M
    Forum (Genova); 2002; 12(1):36-40. PubMed ID: 12634909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low locoregional recurrence rate among node-negative breast cancer patients with tumors 5 cm or larger treated by mastectomy, with or without adjuvant systemic therapy and without radiotherapy: results from five national surgical adjuvant breast and bowel project randomized clinical trials.
    Taghian AG; Jeong JH; Mamounas EP; Parda DS; Deutsch M; Costantino JP; Wolmark N
    J Clin Oncol; 2006 Aug; 24(24):3927-32. PubMed ID: 16921044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Taxanes in the adjuvant treatment of early breast cancer, emerging consensus and unanswered questions.
    Tang SC
    Cancer Invest; 2009 Jun; 27(5):489-95. PubMed ID: 19479486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicycle dose-intensive chemotherapy for women with high-risk primary breast cancer: results of International Breast Cancer Study Group Trial 15-95.
    ; Basser RL; O'Neill A; Martinelli G; Green MD; Peccatori F; Cinieri S; Coates AS; Gelber RD; Aebi S; Castiglione-Gertsch M; Viale G; Price KN; Goldhirsch A
    J Clin Oncol; 2006 Jan; 24(3):370-8. PubMed ID: 16421418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.